MRVL vs NEUP · P/E 100, rev $5.16B vs rev $15.7M
Marvell Technology Group Ltd (MRVL) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the MRVL and NEUP stock pages for the full models.
Not investment advice.